C Abeli

763 total citations
9 papers, 275 citations indexed

About

C Abeli is a scholar working on Infectious Diseases, Virology and Oncology. According to data from OpenAlex, C Abeli has authored 9 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Virology and 1 paper in Oncology. Recurrent topics in C Abeli's work include HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (8 papers) and HIV/AIDS drug development and treatment (7 papers). C Abeli is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (8 papers) and HIV/AIDS drug development and treatment (7 papers). C Abeli collaborates with scholars based in Italy, United States and United Kingdom. C Abeli's co-authors include Teresa Bini, Fulvio Adorni, Letizia Testa, Elisabetta Chiesa, Salvatore Sollima, Antonella d’Arminio Monforte, Mauro Moroni, Massimo Musicco, Massimo Galli and Stefano Rusconi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and AIDS.

In The Last Decade

C Abeli

9 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C Abeli Italy	7	229	177	59	45	35	9	275
Eugénio Teófilo Portugal	9	254 1.1×	178 1.0×	63 1.1×	74 1.6×	17 0.5×	22	319
Elisabetta Chiesa Italy	11	306 1.3×	242 1.4×	96 1.6×	63 1.4×	7 0.2×	17	351
Mark Becker United States	9	453 2.0×	399 2.3×	87 1.5×	53 1.2×	24 0.7×	10	520
Frank-D. Goebel Germany	5	260 1.1×	230 1.3×	114 1.9×	74 1.6×	10 0.3×	7	348
Joseph J. Eron United States	5	261 1.1×	183 1.0×	45 0.8×	58 1.3×	30 0.9×	6	307
María Rivero Spain	9	174 0.8×	132 0.7×	77 1.3×	81 1.8×	29 0.8×	20	271
Anouk M Kesselring Netherlands	6	249 1.1×	220 1.2×	112 1.9×	76 1.7×	14 0.4×	6	308
Sharlaa Badal‐Faesen United States	9	161 0.7×	109 0.6×	71 1.2×	39 0.9×	11 0.3×	16	232
G Moyle United Kingdom	7	158 0.7×	112 0.6×	56 0.9×	35 0.8×	9 0.3×	16	194
Stephan Klauke Germany	10	252 1.1×	201 1.1×	90 1.5×	75 1.7×	20 0.6×	24	332

Countries citing papers authored by C Abeli

Since Specialization

Citations

This map shows the geographic impact of C Abeli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Abeli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Abeli more than expected).

Fields of papers citing papers by C Abeli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Abeli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Abeli. The network helps show where C Abeli may publish in the future.

Co-authorship network of co-authors of C Abeli

This figure shows the co-authorship network connecting the top 25 collaborators of C Abeli. A scholar is included among the top collaborators of C Abeli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Abeli. C Abeli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Adorni, Fulvio, Renato Maserati, Marco Lodi, et al.. (2020). 96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation. SHILAP Revista de lepidopterología. 21(1). 34–43. 5 indexed citations

2.

Trotta, Maria Paola, Alessandro Cozzi‐Lepri, Adriana Ammassari, et al.. (2010). Rate of CD4⁺Cell Count Increase over Periods of Viral Load Suppression: Relationship with the Number of Previous Virological Failures. Clinical Infectious Diseases. 51(4). 456–464. 11 indexed citations

3.

Martinelli, Canio, Elena Ricci, Francesca Vichi, et al.. (2009). Efficacy and safety of boosted and unboosted atazanavir‐containing antiretroviral regimens in real life: results from a multicentre cohort study. HIV Medicine. 11(1). 40–45. 26 indexed citations

4.

Bongiovanni, Marco, Nicola Gianotti, Elisabetta Chiesa, et al.. (2007). Observational Study on HIV-Infected Subjects Failing HAART Receiving Tenofovir Plus Didanosine as NRTI Backbone. Infection. 35(6). 451–456. 3 indexed citations

5.

Bini, Teresa, Letizia Testa, Elisabetta Chiesa, et al.. (2000). Outcome of a Second-Line Protease Inhibitor–Containing Regimen in Patients Failing or Intolerant of a First Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(2). 115–122. 30 indexed citations

6.

Bini, Teresa, Letizia Testa, Elisabetta Chiesa, et al.. (2000). Outcome of a Second-Line Protease Inhibitor–Containing Regimen in Patients Failing or Intolerant of a First Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(2). 115–122. 12 indexed citations

7.

Adorni, Fulvio, Barbara Castelnuovo, Teresa Bini, et al.. (1999). CD4 cell counts at the third month of HAART may predict clinical failure. AIDS. 13(13). 1669–1676. 44 indexed citations

8.

Nebuloni, Manuela, Antonella Tosoni, Renzo Boldorini, et al.. (1999). BK Virus Renal Infection in a Patient With the Acquired Immunodeficiency Syndrome. Archives of Pathology & Laboratory Medicine. 123(9). 807–811. 32 indexed citations

9.

Monforte, Antonella d’Arminio, Letizia Testa, Fulvio Adorni, et al.. (1998). Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection. AIDS. 12(13). 1631–1637. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact